Commonwealth Equity Services’s Precision BioSciences DTIL Stock Holding History

Commonwealth Equity Services’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$620K	Buy	112,671 +19,365	+21%	+$89.3K	﹤0.01%	3020
2025 Q4	$388K	Buy	93,306 +37,461	+67%	+$213K	﹤0.01%	3412
2025 Q3	$308K	Buy	55,845 +2,450	+5%	+$11.7K	﹤0.01%	3610
2025 Q2	$224K	Buy	53,395 +16,240	+44%	+$80.1K	﹤0.01%	3827
2025 Q1	$177K	Buy	37,155 +24,462	+193%	+$125K	﹤0.01%	3872
2024 Q4	$48K	Buy	+12,693	New	+$92.7K	﹤0.01%	3985
2022 Q3	–	Sell	-356	Closed	-$17K	–	3689
2022 Q2	$17K	Buy	356 +14	+4%	+$822	﹤0.01%	3582
2022 Q1	$31K	Buy	+342	New	+$46.5K	﹤0.01%	3627

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Commonwealth Equity Services's DTIL Position: Q1 2026 in Review

Commonwealth Equity Services increased its Precision BioSciences (DTIL) stake by 21% in Q1 2026, buying an estimated $89.3K and bringing the position to 112,671 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

Commonwealth Equity Services first reported a position in DTIL in Q1 2022 and has held it in 8 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Commonwealth Equity Services held 112,671 shares of Precision BioSciences worth $620K as of Q1 2026.
Commonwealth Equity Services bought 19,365 Precision BioSciences shares in Q1 2026, an estimated $89.3K.
Precision BioSciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3020 holding.
Commonwealth Equity Services first reported a position in Precision BioSciences in Q1 2022 and has held it in 8 quarters since.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.